口服化疗的患者选择

Patient selection for oral chemotherapy.

作者信息

Sharma S

机构信息

Memorial Sloan-Kettering Cancer Center, Medical College of Cornell University, New York, New York, USA.

出版信息

Oncology (Williston Park). 2001 Jan;15(1 Suppl 2):33-5.

PMID:11219975

Abstract

Oral chemotherapy has evolved with several new agents such as capecitabine and UFT in active clinical trials or already approved for use in the western world. Several distinct issues, apart from the usual criteria for selecting patients for intravenous chemotherapy, dictate patient selection for these drugs. This article discusses these issues, which include patient preference, selection, and compliance.

摘要

口服化疗随着几种新药物的出现而不断发展，如卡培他滨和优福定，它们正在进行积极的临床试验，或者已在西方世界获批使用。除了选择静脉化疗患者的常规标准外，还有几个不同的问题决定了这些药物的患者选择。本文将讨论这些问题，包括患者的偏好、选择和依从性。